Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Enrolling By Invitation NCT06472817

Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men

Conditions: Prostate Carcinoma

Sex: Male
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 80
Sponsor: Mayo Clinic

Location: Georgia State University Atlanta Georgia

Summary

This study is being done to understand what social factors affect health decisions for those who have immigrated from another country by examining how the immigration from Sub-Sahara Africa affects the experiences of participants regarding health-seeking behaviors, care, and treatment of prostate cancer. It also examines similarities and differences among participants based on their region of origin in Africa.

Eligibility Criteria

Inclusion Criteria: * PHASE I: * Adult men originally from each of these geographic regions (East, West, Central, and Southern Africa) and have been diagnosed with prostate cancer * Able to provide written consent and conduct an interview * Able to speak and understand English * PHASE II: * Caribbean Immigrant men and SSAI men diagnosed with CaP within the last 10 years who identify as Black and speak English * Able to provide written consent and conduct an interview * Able to speak and understand English Exclusion Criteria: * PHASE I: * Patients below the ages of 18, and those not belonging to any of four regions * Employees of Mayo Clinic will be excluded * Non-English speakers will not be included * PHASE II: * Individuals below the age of 18 * Those not diagnosed with prostate cancer and individuals not from the regions described above * Employees of Mayo Clinic will be excluded * Non-English speakers will not be included

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06472817). StuddyBuddy aggregates publicly available trial information.